AI meets early-phase trials in Australia

From faster approvals in Brazil to AI-driven design in Australia, this edition highlights the shifts helping sponsors move early-phase studies forward—faster and more effectively across Latin America and beyond: Discover why many sponsors are rethinking site selection Get up to speed o

ANVISA · AI

From faster approvals in Brazil to AI-driven design in Australia, this edition highlights the shifts helping sponsors move early-phase studies forward—faster and more effectively across Latin America and beyond:

Discover why many sponsors are rethinking site selection Get up to speed on Brazil’s ANVISA overhaul and AnvisAI Explore how AI is accelerating early-phase planning in Australia

Let’s dive in 👇

← All Global Trial Accelerators editions · Contact bioaccess®